Arrhythmias in the Muscular Dystrophies

Cardiac Electrophysiology Clinics

Volumn 7, Issue 2, 2015, Pages 303-308

  Rajdev, Archana ^a   Groh, William J ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Arrhythmia; Genetics; Implantable cardioverter defibrillator; Muscular dystrophy; Pacemaker; Sudden cardiac death

Indexed keywords

GLYCOPROTEIN;

BECKER MUSCULAR DYSTROPHY; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; ELECTROCARDIOGRAPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE MUTATION; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEREDITY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY; PACEMAKER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ARRHYTHMIAS, CARDIAC; HUMANS; MUSCULAR DYSTROPHIES;

EID: 84930274382     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2015.03.011     Document Type: Review

References (27)

1. Spurney C.F. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 2011, 44:8.
2. Melacini P., Fanin M., Miorin M., et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 1996, 94:3168-3175.
3. D'Orsogna L., O'Shea J.P., Miller G. Cardiomyopathy of Duchenne muscular dystrophy. Pediatr Cardiol 1988, 9:205-213.
4. Perloff J.K., Roberts W.C., Leon A.C., et al. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med 1967, 42:179-188.
5. Thrush P.T., Allen H.D., Viollet L., et al. Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy. Am J Cardiol 2009, 103:262.
6. Corrado G., Lissoni A., Beretta S., et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2002, 89:838.
7. Yotsukura M., Yamamoto A., Kajiwara T. QT dispersion in patients with Duchennes muscular dystrophy. Am Heart J 1999, 137:62.
8. Chenard A.A., Becane H.M., Tertrain F., et al. Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul Disord 1993, 3:201-206.
9. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9:77.
10. Eagle M., Baudouin S.V., Chandler C., et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002, 12:926-929.
11. Connuck D.M., Sleeper L.A., Colan S.D., et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008, 155:998-1005.
12. Brook J.D., McCurrach M.E., Aburatani H., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 69:385.
13. Höweler C.J., Busch H.F., Geraedts J.P., et al. Anticipation in myotonic dystrophy: fact or fiction?. Brain 1989, 112:779-797.
14. Rau F., Freyermuth F., Fugier C., et al. Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol 2011, 18:840.
15. Lazarus A., Varin J., Babuty D., et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. JAm Coll Cardiol 2002, 40:1645-1652.
16. Nishioka S., Filho M., Marie S., et al. Myotonic dystrophy and heart disease: behavior of arrhythmic events and conduction disturbances. Arq Bras Cardiol 2005, 84:330-336.
17. Babuty D., Fauchier L., Tena-Carbi D., et al. Significance of late ventricular potentials in myotonic dystrophy. Am J Cardiol 1999, 84:1099-1101.
18. Groh W.J., Groh M.R., Chandan S., et al. Electrocardiographic abnormalities and risk of sudden death in myotonic dystrophy type 1. NEngl J Med 2008, 358:2688.
19. Epstein A., Dimarco J., Ellenbogen K., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 2008, 117:e350.
20. Maury P., Audoubert M., Razcka F., et al. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: myotonic dystrophy as a part of the Brugada syndrome. Heart Rhythm 2014, 11(10):1721-1727.
21. Russo A., Mangiola F., Bella P., et al. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. JCardiovasc Med (Hagerstown) 2009, 10:51-58.
22. Manilal S., Nguyen T.M., Sewry C.A., et al. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet 1996, 5:801-808.
23. Boriani G., Gallina M., Merlini L., et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke 2003, 34:901-908.
24. Merlini L., Granata C., Bonfiglioli S., et al. Emery-Dreifuss muscular dystrophy: report of five cases in a family and review of the literature. Muscle Nerve 1986, 9:481-485.
25. Fanselme G., Moubarak A., Savouré A., et al. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. Heart Rhythm 2013, 10(10):1492-1498.
26. Berlo J.H., Voogt W.G., Kooi A.J., et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?. JMol Med 2005, 83:79-83.
27. Meune C., Van Berlo J.H., Anselme F., et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. NEngl J Med 2006, 354:209-210.